Stem cell biotech Magenta Therapeutics files for a $100 million IPO – Nasdaq
Nasdaq |
Stem cell biotech Magenta Therapeutics files for a $100 million IPO
Nasdaq Magenta Therapeutics, which is developing novel therapies to make stem cell transplants more effective, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. The Cambridge, MA-based company was founded in 2015 by … |
